TCL Archive FDA Approves Gilotrif Tablets in NSCLC, Boehringer Ingelheim’s First Approved Cancer Drug July 26, 2013
TCL Archive DCT Board Okays Extension Of Phase 1 Master Agreements, Increase To $4 Million February 27, 1987
TCL Archive In Brief: Ross Retires From Bristol-Myers, Forms Own Consulting Service; Obey Wins Key Post April 1, 1994
